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Purpose: To evaluate in vitro (using human hepatoma HepG2 cells) and in vivo (using mouse liver with 
diethlynitrosamine (DEN)-induced hepatocarcinogenesis) effect of a standardized decoction on the 
expression of p53 (tumour suppressor) and p21 (cyclin kinase inhibitor) genes with the long-term goal of 
developing the formulation into a globally acceptable therapy for hepatocellular carcinoma (HCC).  
Methods: The effect of the decoction on (a) mRNA and (b) protein expression of p53 and p21 genes in 
HepG2 cells and mouse livers with DEN-induced early hepatocarcinogenesis were evaluated by (a) 
reverse transcription PCR (RT-PCR) and (b) immunohistochemical and Western blot analysis, 
respectively.   
Results: The results demonstrated that the decoction significantly (p < 0.001) enhanced the expression 
of p53 and p21 genes in a time- and dose-dependent manner in HepG2 cells. A dose of 75 µg/ml 
significantly increased p53 mRNA at 24 and 48 h and p21 mRNA at 12, 24, 48 h of incubation with the 
decoction (p < 0.01). Induction of hepatocarcinogenesis in mice significantly increased hepatic 
expression of both p53 and p21 compared to distilled water control (p < 0.001), while treatment with the 
decoction further enhanced expression of both genes in DEN-induced hepatocarcinogenesis (p < 0.01).  
Conclusion: Overall, the findings demonstrate that the decoction may mediate its reported 
antihepatocarcinogenic effect, at least in part, through the modulating activities of genes involved in 
tumour suppression and cell cycle arrest.  
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INTRODUCTION 
 
Hepatocellular carcinoma (HCC) is the most 
frequent primary liver cancer and the fifth 
commonest neoplasm in the world. Despite 
the availability of curative surgical methods, 
the recurrence rate of HCC is reported to be 
as high as 50 % at 2 years [1]. Similarly, 
adjunct therapies such as radiotherapy, 
chemotherapy and hormonotherapy have not 
reduced the number of deaths from HCC to 
the expected level [2]. Further, these 
treatments produce some very unpleasant 
side effects such as toxicity to normal cells, 
bone marrow depletion, adverse effects on 
the gastro-intestinal tract etc. Therefore, 
there is an urgent need to search for better 
control and preventive methods that would 
not only reduce mortality of HCC patients, but 
would also have less side effects. 
 
In many Asian countries, some poly-herbal 
preparations are considered by traditional 
medical practitioners to be useful for the 
treatment of cancer, despite lack of evidence 
from scientifically controlled studies to 
validate these claims. One such remedy that 
has been used for many years by a particular 
family of Ayurveda physicians in Sri Lanka is 
a decoction comprised of Nigella sativa 
seeds, Hemidesmus indicus roots and Smilax 
glabra rhizomes [3,4]. Previous in vivo 
investigations confirmed that this decoction 
protects against chemically induced 
carcinogenesis in rat liver, with no significant 
toxic side effects, thus providing support for 
its ethnopharmacological use for cancer 
therapy [3,4]. In the past few years, with the 
sequencing of the human genome providing 
us with an enormous number of potential 
targets associated with cancer, the focus of 
drug development for cancer therapy has 
moved from cytotoxic compounds identified 
by screening to identification of compounds 
that can act at specific molecular targets 
associated with carcinogenesis.  p53 is a 
tumour suppressor gene that plays an 
important role in maintaining genetic stability 
and cell cycle regulation after induction of 
DNA damage. It is the most commonly 
mutated gene in human cancers [5]. p21, is a 
cyclin kinase inhibitor (CKI) involved in cell 
growth arrest [6]. Expression of p21 is 
controlled at the transcriptional level by both 
p53 dependent and -independent 
mechanisms [7]. Since the integrity of p53 
has been reported to be critical in cancer 
predisposition, onset and therapeutic 
response, interventions to restore wild-type 
p53 is an attractive approach for cancer 
therapy [8]. Therefore, identification of natural 
agents that can restore wild-type p53 (wt 
p53) may lead to the development of novel 
drugs for cancer treatment. 
 
The aim of the present investigation was to 
evaluate in vitro (using human hepatoma 
HepG2 cells) and in vivo (using mouse liver 
with diethyl nitrosamine induced hepatocarci-
nogenesis), the effect of a standardized 
decoction comprised of N. sativa seed, H. 
indicus root and S. glabra rhizome on the 
expression of p53 (tumour suppressor) and 
p21 (cyclin kinase inhibitor) genes with the 
long term goal of developing the above 
herbal formulation into a form that could be 
used by itself or as an adjunct to existing 




Collection of plant material  
 
Plant materials for the preparation of extracts 
were purchased from a reputed vendor of 
herbal material used by traditional medical 
practitioners in Sri Lanka (D.J. Fernando Pvt 
Ltd, Gabose Lane, Colombo 13). Their 
identities were confirmed by a taxonomist 
(Mr. Gunarathne Silva) of the Bandara-
nayaka, Memorial Ayurvedic Research 
Institute (BMARI), Navinna, Maharagam, Sri 
Lanka. Voucher specimens of N. sativa seed, 
H. indicus root, and S. glabra rhizome (nos. 
UOC/IBMBB/2009/01, UOC/IBMBB/2009/02 
and UOC/IBMBB/2009/03, respectively) were 
deposited at the herbarium of the Institute of 
Biochemistry, Molecular Biology and 
Biotechnology, University of Colombo, Sri 
Lanka. 
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Preparation of plant decoction 
 
The plant decoction was prepared according 
to the method recommended traditionally for 
administration to cancer patients [3,4]. Sixty 
grams (60 g) of plant material (composed of a 
mixture of 20 g each of N. sativa seeds, H. 
indicus roots and S. glabra rhizomes) were 
ground and boiled gently with 1.6 L distilled 
water for approximately 3 h to reduce the 
volume to 200 ml. The extract was then 
filtered through a layer of muslin, the filtrate 
centrifuged at 3000 g for 15 min to remove 
any debris, and the supernatant freeze-dried 
and stored at -20 
0
C until required. Prior to 
use, the freeze-dried extract was 
reconstituted with the appropriate volume of 
distilled water containing 1 % DMSO. 
 
HepG2 cell culture and treatment  
 
HepG2 cells (ECACC, Salisbury, UK) were 
grown in monolayer cultures in Dulbecco's 
Modified Eagle Medium (DMEM) 
supplemented with 10% fetal bovine serum, 
and 50 IU/ml penicillin and 50 µg/ml 
streptomycin. The cells were maintained at 
37 
0
C in 95 % air / 5 % CO2 atmosphere, and 
95 % humidity. The media were purchased 
from GIBCO, Invitrogen Corporation, U.S.A, 
while other chemicals were obtained from 
Sigma Aldrich (Gillingham, Dorset, UK). The 
cells were harvested by trypsinization and 2 x 
10
5
 cells / flask were seeded into 18 T25 (25 
cm
2
) flasks. Cell cultures were initially 
maintained in DMEM medium (5 ml) for 24 h 
at 37 
0
C in 95 % air/5% CO2 atmosphere, and 
95 % humidity. After 24 h, the medium from 
each flask was replaced with fresh medium 
and cell cultures were treated with different 
concentrations of the decoction. The 
concentrations used were 75, 150, 300, 600, 
and 1200 µg/ml, and triplicate cell cultures 
were exposed to each concentration. Control 
cell cultures received only medium containing 
1 % DMSO. Treated and control cell cultures 
were incubated for a further 12, 24 or 48 h. At 
the end of the incubation period, the cells 
were harvested and (a) total RNA and protein 
were extracted for the reverse transcription 
PCR (RT- PCR) quantification of p53
wt 
and 
p21 genes, and western blot analyses of 
p53
wt 
and p21 proteins, respectively, or (b) 
immunohistochemical focusing of the p53
wt  
and p21 proteins.  
 
The viability of cells (2 x 10
5
 cells/ml) 
incubated with the decoction for 12, 24 and 
48 h with different doses of the decoction 
were evaluated by the MTT assay [9] as 
described previously [10]. 
 
Experimental animals and treatments 
 
C3H male mice (5-6 weeks old) were 
purchased from the Medical Research 
Institute (M.R.I.), Colombo, Sri Lanka. They 
were housed in a temperature–controlled 
room (25 ± 2 
0
C) and maintained on a 
standard laboratory diet, prepared by the 
M.R.I. according to a formula recommended 
by the WHO [11], and water ad libitum. 
Ethical clearance for the animal experiments 
was obtained from the Ethical Review 
Committee of the M.R.I., Colombo, Sri Lanka. 
The animals were maintained in accordance 
with guidelines for ethics review of research 
proposals involving animals in Sri Lanka [12].  
 
A total of thirty two (n = 32) male C3H mice (5 
- 6 weeks old) were randomly divided into 
four equal groups (8 mice/group). The mice in 
group 1 (distilled water control group) were 
orally fed with distilled water for a period of 
four weeks. Mice in group 2 (decoction 
control group) were orally fed with the 
decoction at a dose of 10 g/kg body 
weight/day for four weeks. This dose was 
based on the decoction dose which 
demonstrated maximum anti-
hepatocarcinogenic effects against diethyl-
nitrosamine (DEN)-induced HCC in rats [3]. 
Distilled water or decoction was orally 
administered to mice via a Sondi needle [3]. 
Mice in group 3 (positive control group) and 
group 4 (test group) were  injected with DEN 
in 0.9 % NaCl at a dose of 20 µg/g body 
weight as a single intraperitoneal injection on 
day 1 to initiate hepatocarcinogenesis [13]. 
Throughout the experiment, the animals had 
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free access to standard diet and water. From 
day 2 onwards, DEN-induced animals in the 
positive control and test groups were orally 
administered distilled water and the decoction 
(at a dose of 10g/kg body weight/day) 
respectively, for a period of four weeks. 
Animals in the test and positive control 
groups were subjected to a second dose of 
DEN (20 µg/g body weight, i.p.), 30 min. 
before they were sacrificed [14]. At the end of 
the fourth week, liver specimens from all 
animals were excised under diethyl ether 
anaesthesia, immediately washed with 
RNase-free ice cold phosphate buffered 
saline (pH 7.4) and used for (a) RT-PCR 
quantification of p53 
wt 
and p21 genes, (b) 




proteins,  and (c) immunohistochemical 
focusing of the  p53 
 
and p21 proteins. 
 
Isolation of total RNA and RT-PCR 
analysis 
 
Total RNA was isolated from the HepG2 
cells, or liver sections from C3H/H mice, 
using TRIzol reagent (Invitrogen, Life 
Technologies; USA) according to the 
manufacturer’s specifications. Total RNA 
concentration in the final elutes was 
determined by using a spectrophotometer 
(UV-1700, pharmasprc, Shimadzu, Japan). 
Each sample of isolated RNA was reverse-
transcribed by M-MLV reverse transcriptase 
system (A3500, Promega Cooperation, 
Madisons, U.S.A) to synthesize single 
stranded cDNA as follows. RNA sample (2µg) 
was initially mixed with 0.5µg of random 
primers. Subsequently, RNA-random primer 
mix was incubated for 60 min at 37
0
C in 
reverse transcription reaction mix containing 
5µg M-MLV 5X reaction buffer, 10 mM dNTP 
mix, 25 units of RNasin and 200 units of M-
MLV reverse transcriptase in PCR water 
adjusted to 25 µl.  
 
GAPDH amplification was performed as an 
internal control. Each PCR was carried out in 
a master mix containing 1X Green Go Taq 
Flexi Buffer, 2 mM MgCl2, 10 mM dNTPs and 
1.25 U GoTaq DNA polymerase (Promega 
Inc. US) with 0.2 mM of respective forward 
and reverse  primers in 50 µl reaction mix. 
PCR amplification was carried out in a 
Mastercycler (Eppendorf, Hamburg, 
Germany) and the PCR conditions for both 
human and mouse GAPDH were 30 cycles at 
94
 o
C for 30 s, at 54
 o
C for 30 s, at 72
 o
C for 1 
min. PCR conditions for both human and 
mouse p53 were 35 cycles at 94
 o
C for 1.5 
min, at 55
 o
C for 1 min, at 72
 o
C for 1 min. 
PCR conditions for mouse p21 were 30 
cycles at 94
 o
C for 1.5 min, at 62
 o
C for 1 min, 
at 72
 o
C for 1 min and for human p21 were 35 
cycles at 94
 o
C for 1.5 min, at 52
 o
C for 1 min, 
at 72
 o
C for 1 min. Primers were purchased 
from Integrated DNA Technologies, USA. 
These were,  human p53: forward primer 5`- 
GTTCCGAGAGCTGAATGAGG-3`, reverse 
primer 5`-TCTGAGTCAGGCCCTTCTGT-3`; 
human GAPDH : forward primer 5`-
GAAGGTGAAGGTCGGAGTC-3`, reverse 
primer 5`-GAAGATGGTGATGGGATTTC-3`; 
human p21: forward primer 5-
GTCACCCTCCAGTGGTGTCT-3’, reverse 
primer 5’- TGCGTTCACAGGTGTTTCTG-3’; 
mouse p53: forward primer 5’- 
CCCGAGTATCTGGAAGAC AG – 3’, reverse 
primer 5’- ATAGGTCGGCGGTTCAT – 3’; 
mouse GAPDH: forward primer 5’ - 
GAGGGGCCATCC ACAGTCTTC – 3’, 
reverse primer 5’ - 
CATCACCATCTTCCAGGAGCG – 3’ ;and  
mouse p21: forward primer 5’-




Amplified PCR products were subjected to 
electrophoresis at 40 V through 2% agarose 
gel (Sigma, U.S.A) for 60 min. A 100 bp DNA 
ladder marker was used as a molecular 
marker. Gels were stained with 0.5 mg/ml 
ethidium bromide in TAE buffer. The gel 
bands were examined by using a Gel Doc 
imaging system and the intensity of each 
band was measured by using BIO RAD 
quantity one soft ware. The size of the 
amplified PCR products were 159 bp for 
human p53, 150 bp for mouse p53, 216 bp 
for human p21, 311 bp for mouse p21, and 
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226 bp for human GAPDH and 350 bp for 
mouse GAPDH.  
 
Western blot analysis 
 
For in vitro evaluation of p53 and p21 
proteins in HepG2 cells by western blot 
analysis, cells were harvested after 12, 24 
and 48 h incubation by trypsinization, and 
centrifuged at 1000 g for 10 min at 4 
o
C. The 
pelleted cells were solubilized for 15 min at 4 
°C in lysis buffer [50 mM Tris-HCl pH 7.4, 150 
mM NaCl, 1 mM EDTA, 1 % Nonidet P-40, 
0.25 % Na-deoxycholate, 1 mM PMSF 
(phenylmethylsulfonyl fluoride) and 
proteinase inhibitor cocktail]. Lysates were 
centrifuged at 12,000 g for 15 min at 4 °C to 
remove insoluble material. The supernatant 
was collected and protein concentration was 
determined using the Bradford’s reagent. For 
Western blot analysis, samples (40 µg each) 
were separated by electrophoresis on 10 % 
SDS-polyacrylamide gels and transferred 
onto nitrocellulose membrane. 
 
For evaluation of p53 and p21 protein 
expression in mouse liver, frozen mouse liver 
sections (200 mg of each liver specimen) 
were completely homogenized in 5 ml of ice 
cold RIPA buffer (50mM Tris-HCl pH 7.4, 
150mM NaCl, 1mM EDTA, 1 % NP40, 0.25 
% Na-deoxycholate, 1 mM PMSF [phenyl-
methylsulfonyl fluoride] supplemented with 
proteinase inhibitor cocktail containing 
aprotinin and leupeptin). Homogenate was 
immediately centrifuged at 12,000 g for 15 
min at 4 
0
C and the protein content of the 
supernatant was evaluated by Bradford’s 
reagent using pre-plot standard curve. Equal 
amount (40µg) of liver protein lysate of each 
experimental group were separated by 10% 
SDS-PAGE and transferred overnight on to 




Nitrocellulose membranes onto which protein 
extracted from HepG2 cells and mouse livers 
were transferred were pre-blocked with 5% 
non fat dry milk in PBS for 30 min. Then the 
membranes were incubated for 16 h at 4 °C 
before incubating with specific primary 
antibodies which detect both human and 
mouse proteins. Bands were normalized 
using β-actin antibody (Santa Cruz 
Biotechnology, Santa Cruz, CA). After three 
washes of 10 min each with 1x TBST (50mM 
Tris-HCl, pH7.4, 150mM NaCl, 1 % Tween 
20), each membrane was incubated with the 
secondary antibody for 30 min at room 
temperature. The membrane was then 
washed three times with TBST (10 min/wash) 
and bands visualized using western blot 
detection system (Santa Cruz Biotechnology, 
Santa Cruz, CA).  
 
Immunohistochemical analysis of p53 
expression in HepG2 cells and mouse 
liver 
 
Sample preparation  
 
HepG2 cells were harvested by 
trypsinization, and 2 x 10
5
 cells/ml were 
plated on sterile coverslips placed in wells of 
a 24 well cell culture plate. The cells (on 
coverslips) were initially maintained in DMEM 
medium (1 ml/coverslip) for 24 hrs at 37 
0
C in 
95% air/ 5% CO2 atmosphere, with 95% 
humidity. Cultures were then treated with the 
standardized decoction (600µg/ml or 1200 
µg/ml) and incubated for 24 h. The doses of 
600 µg/ml and 1200 µg/ml decoction were 
selected for this experiment based on the 
doses that produced significant enhancement 
of p53 and p21 gene expression in the 
experiments described above. Cells were 
then washed with phosphate buffer saline 
(PBS), fixed with cold 1:1 acetone: methanol 
for 15 min and air-dried.   
 
Sections of mouse liver were immediately 
fixed in 10% formaldehyde, embedded in 
paraffin. Subsequently, 4 µm sections were 
used for staining after de-paraffinization in 
xylene, and rehydration through graded 
ethanol (AR, 80 – 100 %). p53 and p21 
activities were monitored in de-paraffinized 
tissue sections by exposing each section to 
heat-induced antigen retrieval in 10 mM 
citrate buffer (pH 6.0), using a pressure 
cooker [15]. 
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Immunohistochemical analysis 
 
Primary and secondary antibodies and the 
ABC staining kit were purchased from Santa 
Cruz Biotechnology (Santa Cruz, CA). The 
coverslips with HepG2 cells and slides 
containing deparaffinized mouse liver 
sections were quenched with 1% BSA in 0.05 
M Tris/HCl (pH 7.6) for 30 min, and then 
incubated for 60 min at 37 
0
C with anti-p53 
(sc- 6343) and anti-p21 (sc-397) rabbit 
polyclonal antibodies, diluted 1: 200. After 
washing with PBS (two times), the cells and 
tissue sections were incubated for 60 min 
with goat anti-rabbit IgG-HRP (sc-3837 
diluted 1: 1000), washed again with PBS (two 
times) and visualized with ABC staining kit. 
Cells / tissue sections were counterstained 





The results of RT-PCR were analyzed using 
Prism 2.01 (Graph Pad Prism, San Diego, 
USA). One-way analysis of variance 
(ANOVA) with Dunnett’s post test for multiple 
comparisons was used to find out the 
concentrations and time points at which the 
p53 and p21 expression were significantly 
increased in comparison to controls. Two-
way ANOVA analysis was used to detect the 
effect of different concentrations of the 
decoction and duration of the treatment on 
the mRNA expression of p53 and p21 in 
HepG2 cells. One-way ANOVA with 
Bonferroni post test was used to compare all 
pairs of columns and used to analyze the 





Preparation of plant decoction 
 
The yield of the freeze-dried decoction was 
15.2 ± 0.3.%  
 
 
Effect of decoction on HepG2 cell viability 
 
Alterations in viability of cells incubated for 
12, 24 and 48 h with different doses of the 
decoction are shown in Fig 1. At all three 
post-incubation time points, statistically 
significant differences in viability from zero 
time were observed only at doses above 
1200 µg/ml. Hence, in the experiments to 
evaluate effects on p53 and p21 expression, 
doses of decoction at or below 1200 µg/ml 
were used. 
 
Doses of the decoction (ug/ml)




























Figure 1: Effect of aqueous extract on overall cell 
viability-MTT assay (values are mean ±SEM) 
 
 
Effect of decoction on p53 gene 
expression in HepG2 cells  
 
In the RT-PCR evaluation, p53 gene 
expression was normalized to the house 
keeping GAPDH gene. Results of the RT-
PCR (Fig 2) demonstrated that the 
standardized decoction enhanced p53 mRNA 
expression in human HepG2 cells in a 
significant (p < 0.001) time and dose 
dependant manner. The lowest doses at 
which statistically significant (p < 0.001) p53 
mRNA up regulation was observed at 12, 24 
and 48 h post-incubation were 300, 75 and 
75 µg/ml, respectively. The results of RT-
PCR analysis were supported by findings of 
the immunohistochemical evaluation and 
Western blot analysis of the p53 protein 
expression in HepG2 cells (Fig 3). 
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Figure 2: Effect of decoction on mRNA expression 
of p53 gene in HepG2 cells (*p <0.05, **p < 0.01 
when compared to control) 
 
Effect of decoction on p21 gene 
expression in HepG2 cells  
 
As with p53, p21 gene expression was also 
normalized to the house keeping GAPDH 
gene. RT-PCR evaluation (Fig. 4) showed 
that in HepG2 cells, the standardized 
decoction induced over expression of p21 
mRNA in a significant (p < 0.001) time and 
dose dependant manner. The lowest dose at 
which statistically significant (p < 0.01) p21 
mRNA up regulation was observed at 12, 24 
and 48 h post-incubation was 75 µg/ml. 
 
The results of RT-PCR analysis were 
supported by findings of the western blot 
analysis and immunohistochemical analysis 
of the p21 protein expression in HepG2 cells 
(Figs 3B and 5A). 
 
 
Figure 3: Immunohistochemical analysis of p53 and p21 in HepG2 cells and mouse liver. Expression of 
p53 (A) and p21 (B) protein in HepG2 cells (shown by arrows) was confirmed by immunohistochemical 
analysis: [a] control (untreated) [b] treated with the decoction (600 µg/ml), [c] treated with the decoction 
(1200 µg/ml). Section [d] represents the negative control. Expression of p53 (C) and p21 (D)  protein 
(shown by arrows) in mouse liver [a] neither induced with DEN nor treated with the decoction (normal 
control), [b] treated with the decoction after induction, [c] induced with DEN, [d] the negative control. 
Hematoxyline was used for counterstaining    
 **  
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Figure 4: Effect of decoction on mRNA expression 
of p21 gene in HepG2 cells (*p < 0.05, **p <0.01 
when compared to the control)  
 
 
Effect of decoction on p53 and p21 gene 
expression in mouse liver  
 
In mice treated only with DEN, an increased 
p53 expression was observed (on RT-PCR 
evaluation of p53 mRNA) in comparison to 
livers of animals not exposed to this 
hepatocarcinogen (Fig 6a). A similar increase 
was also observed with p21 (Fig 6b). 
However, as evident from Fig 6, expression 
of both p53 and p21 genes were significantly 
(p < 0.01) further up-regulated by 
administration of the decoction to post-DEN 
treated mice, although the decoction by itself 
did not significantly modulate the expression 
of either gene.  
 
Immunohistochemical and western blot 
analysis evidence shown in Figs 3 (C,D) and 
5 (B) confirm that the decoction can enhance 
expression of both p53 and p21 genes in 





A number of studies carried out over the last 
few decades, especially in China, on 
prevention and treatment of HCC have led to 
the identification of several herbal 
compounds and formulations that can affect  
 















Figure 5: Western blot analysis of effects of the decoction on p53 and p21 expression in HepG2 cells and 
mouse liver with DEN-induced early hepatocarcinogenesis.  
[A]-Western blot analysis of p53 and p21 expression in HepG2 cells treated with different concentrations 
(lane 1-control, lane 2-75 µg/ml, lane 3-150 µg/ml, lane 4-300 µg/ml, lane 5-600 µg/ml, lane 6-1200 µg/ml) 
of the standardized decoction at (a) 12 h post incubation, (b) 24 h post-incubation and (c) 48 h post 
incubation was performed as described in the Materials and Methods section. Normalization of bands was 
performed using β-actin protein. [B] Western blot analysis of p53 and p21 expression in mouse livers with 
DEN-induced early hepatocarcinogenesis treated with the decoction was performed as described in the 
Materials and Methods section. Lane 1 - distilled water control, Lane 2 - decoction only, Lane 3- induced 
with DEN, Lane 4 - treated with the decoction post DEN- induction. 
1    2    3    4    5   6                      1    2    3    4    5   6         1    2    3    4    5   6 
 
(a)                               (b)            (c) 
p21 p53 
β-actin 
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Figure 6: mRNA expression of p53 and p21 in mouse liver (***p < 0.001) compared to distilled water 
control; **p < 0.01 compared to DEN control  
 
the initiation, promotion as well as the 
progression of HCC [13]. Previous 
investigations [3,4] have shown that the 
decoction, comprised of N. sativa seed, H. 
indicus root, and S. glabra rhizome, has anti-
hepatocarcinogenic potential without 
producing any significant toxic side effects. 
Although cytotoxicity [10,16], antioxidant 
activity [17] and anti-inflammatory activity are 
possible anti-cancer mechanisms, the 
underlying molecular mechanisms by which 
the decoction mediates its anti-carcinogenic 
effects have not yet been investigated. 
 
Inappropriate expression of tumor 
suppressor/pro-apoptotic and cell cycle 
related proteins, such as p53 and p21, is 
considered to be one of the major factors 
contributing to HCC development [18]. 
Several mechanisms of apoptosis induction 
by p53 have been identified involving 
transcriptional and/or nontranscriptional 
regulation of its downstream effectors. For 
example, tumor suppressor p53 is known to 
induce apoptosis by transcriptional up-
regulation of pro-apoptotic genes such as 
Bax, NOXA, PUMA, AIP, Apaf-1, and by 
transcriptional repression of Bcl2 and 
inhibitors of apoptosis [19]. 
 
Supportive evidence for the ability of the 
decoction under test to enhance the 
expression of p53 and p21 genes is provided 
by results obtained in the western blot 
analysis.  
 
The Cdk inhibitor p21 is often responsible for 
stress-induced p53-dependent and p53-
independent cell cycle arrest, and 
deregulation
 
of the transcriptional protein p53 
can induce p21/ WAF1 expression
 
which 
inhibits cyclin-dependent kinases for the 
control of both
 
G1 and G2/M checkpoints in 
the cell cycle or trigger apoptosis [20]. 
 
In the present study we have demonstrated 
that transcription (as shown by RT-PCR ) and 
translation (as shown by immunohisto-
chemistry and Western blot analysis) of both 
p53 and p21 genes are significantly 
enhanced in response to the decoction 
comprising of N. sativa seed, H. indicus root, 
and S. glabra rhizome. Up regulation of 
expression of both p53 and p21 genes in a 
time- and dose-dependent manner was 
evident in the human hepatocellular 
carcinoma cell line HepG2 in-vitro and in the 
DEN-induced mouse hepatic cancer model 
in-vivo. Although up regulation of expression 
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alone has been previously reported [21,22], 
we observed further enhancement of p53 
expression in response to the decoction over 
and above DEN-induced p53 expression. It 
has been suggested that the induction of p53 
by DEN is not related to a cytotoxic effect, but 
most likely results from DNA strand breaks 
induced directly by this genotoxic compound 
or formed as a result of DNA-repair [20,21]. 
 
One of the compounds isolated from N. 
sativa seeds is an anticancer compound, 
thymoquinone. We have previously 
demonstrated that thymoquinone is not 
present in the decoction used in the present 
experiment [10]. Therefore, some other 
water-soluble compound(s) is(are) likely to be 
responsible for the up regulation of p53 and 
p21 mRNA, and protein levels observed in 
the present study. Other investigators have 
reported that several plant compounds such 
as resveratrol, curcumin and eurycomanone 
[23] mediate their anti-proliferative effects 
trough apoptosis and cell cycle arrest. 
Decoction comprising of N. sativa seed, H. 
indicus root, and S. glabra rhizome 
investigated in the present study also 
appears to exert anti-proliferative and anti 
carcinogenic effects via apoptosis and cell 
cycle arrest through up regulation of p53 and 




Up regulation of p53 and p21 activity in 
HepG2 cells and mouse liver with DEN-
induced early hepatocarcinogenesis  
suggests that the decoction comprised of N. 
sativa seed, H. indicus root, and S. glabra 
rhizome may mediate its reported 
antihepatocarcinogenic effects at least in 
part, through the modulating activities of 
genes involved in tumour suppression and 
cell cycle arrest. The results provide a new 
insight into the possible molecular 
mechanisms by which the decoction may be 
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